Related references
Note: Only part of the references are listed.Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial
Laurie A. Lee et al.
LANCET RESPIRATORY MEDICINE (2021)
Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
Andrew Menzies-Gow et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
TSLP Inhibitors for Asthma: Current Status and Future Prospects
Maria Gabriella Matera et al.
DRUGS (2020)
Pharmacology and Therapeutics of Bronchodilators Revisited
M. G. Matera et al.
PHARMACOLOGICAL REVIEWS (2020)
Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
Jonathan E. Phillips
FRONTIERS IN PHARMACOLOGY (2020)
Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study
Huib A M Kerstjens et al.
Lancet Respiratory Medicine (2020)
Late Breaking Abstract - LUSTER-1 and-2: randomised controlled trials of fevipiprant in severe asthma
Christopher E. Brightling et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Anti-inflammatory effects of the phosphodiesterase type 4 inhibitor CHF6001 on bronchoalveolar lavage lymphocytes from asthma patients
Thomas Southworth et al.
CYTOKINE (2019)
Phosphodiesterases as therapeutic targets for respiratory diseases
Haoxiao Zuo et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials
Johann Christian Virchow et al.
LANCET (2019)
Severe Eosinophilic Asthma
Agamemnon Bakakos et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Biased TAS2R Bronchodilators Inhibit Airway Smooth Muscle Growth by Downregulating Phosphorylated Extracellular Signal-regulated Kinase 1/2
Donghwa Kim et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)
Therapeutic potential of ectopic olfactory and taste receptors
Sung-Joon Lee et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Immunologic mechanisms in asthma
Tadech Boonpiyathad et al.
SEMINARS IN IMMUNOLOGY (2019)
LPS-induced Lung Platelet Recruitment Occurs Independently from Neutrophils, PSGL-1, and P-Selectin
Simon J. Cleary et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)
Relaxin potentiates β2-adrenoceptor mediated bronchodilation in precision-cut lung slices (PCLS) from mouse models of airway inflammation and fibrosis, and in human airways
Jane Bourke et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Randomized trial to assess the efficacy and safety of beclomethasone dipropionate breath-actuated inhaler in patients with asthma
Nancy K. Ostrom et al.
ALLERGY AND ASTHMA PROCEEDINGS (2018)
Diverse signalling of the platelet P2Y1 receptor leads to a dichotomy in platelet function
Richard T. Amison et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Recent advances in understanding the roles of blood platelets in the pathogenesis of allergic inflammation and bronchial asthma
Tomohiro Takeda et al.
ALLERGOLOGY INTERNATIONAL (2018)
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
Richard J. Russell et al.
LANCET RESPIRATORY MEDICINE (2018)
Sulfated non-anticoagulant heparin blocks Th2-induced asthma by modulating the IL-4/signal transducer and activator of transcription 6/Janus kinase 1 pathway
Mohamed A. Ghonim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
The Fab fragment of anti-IgE Cε2 domain prevents allergic reactions through interacting with IgE-FcεRIα complex on rat mast cells
Takao Hirano et al.
SCIENTIFIC REPORTS (2018)
A dichotomy in platelet activation: Evidence of different functional platelet responses to inflammatory versus haemostatic stimuli
Eleonora Petito et al.
THROMBOSIS RESEARCH (2018)
The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
Christian Domingo et al.
RESPIRATORY RESEARCH (2018)
Comparable efficacy of calcilytic and corticosteroid in short-term and long-term allergic asthma models in vivo
Daniela Riccardi et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Gene-based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling
Manuel A. R. Ferreira et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Follicular helper T cells mediate IgE antibody response to airborne allergens
Takao Kobayashi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Lipopolysaccharide (LPS) induced pulmonary neutrophil recruitment and platelet activation is mediated via the P2Y1 and P2Y14 receptors in mice
R. T. Amison et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2017)
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
Geoffrey L. Chupp et al.
LANCET RESPIRATORY MEDICINE (2017)
Role of muscarinic antagonists in asthma therapy
Mario Cazzola et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2017)
Platelets roll and adhere to the vascular bed in response to allergen challenge in allergic mice
Sajeel Shah et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Gα12 facilitates shortening in human airway smooth muscle by modulating phosphoinositide 3-kinase-mediated activation in a RhoA-dependent manner
Edwin J. Yoo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
The Biology of Eosinophils and Their Role in Asthma
Claire N. McBrien et al.
FRONTIERS IN MEDICINE (2017)
Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies
Paul Ratner et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2017)
P2Y12 antagonist attenuates eosinophilic inflammation and airway hyperresponsiveness in a mouse model of asthma
Dong-Hyeon Suh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Pharmacokinetics, Pharmacodynamics, and Safety of MEDI4212, an Anti-IgE Monoclonal Antibody, in Subjects with Atopy: A Phase I Study
Eric Sheldon et al.
ADVANCES IN THERAPY (2016)
A Non-Anticoagulant Fraction of Heparin Inhibits Leukocyte Diapedesis into the Lung by an Effect on Platelets
Yanira Riffo-Vasquez et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Understanding how long-acting β2-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update
Robert Newton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Follicular helper T cells are responsible for IgE responses to Der p 1 following house dust mite sensitization in mice
A. Noble et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen- induced early asthmatic responses
Gail M. Gauvreau et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled Trial
J. R. Anderson et al.
PLOS ONE (2016)
Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma
Arnab Ghosh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma
Veit J. Erpenbeck et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
Pharmacology of Heparin and Related Drugs
Barbara Mulloy et al.
PHARMACOLOGICAL REVIEWS (2016)
A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma
Jeffrey M. Harris et al.
RESPIRATORY RESEARCH (2016)
RPL554, an inhaled PDE3/4 inhibitor, causes comparable bronchodilation to high dose nebulised salbutamol in asthmatics with fewer systemic effects
Leif Bjermer et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Rosiglitazone elicits in vitro relaxation in airways and precision cut lung slices from a mouse model of chronic allergic airways disease
Chantal Donovan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Taste receptors in asthma
Stanislas Grassin-Delyle et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment
Girolamo Pelaia et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
A novel, nonanaphylactogenic, bispecific IgE-CD3 antibody eliminates IgE1+ B cells
Oktay Kirak et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
RhoA signaling through platelet P2Y1 receptor controls leukocyte recruitment in allergic mice
Richard T. Amison et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Targeting Mast Cells and Basophils with Anti-FcεRlα Fab-Conjugated Celastrol-Loaded Micelles Suppresses Allergic Inflammation
Xia Peng et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2015)
Calcium-sensing receptor antagonists abrogate airway hyperresponsiveness and inflammation in allergic asthma
Polina L. Yarova et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD
Karin A. L. Mueller et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Sputum eosinophilia is a determinant of FEV1 decline in occupational asthma: results of an observational study
Donatella Talini et al.
BMJ OPEN (2015)
P-Rex and Vav Rac-GEFs in platelets control leukocyte recruitment to sites of inflammation
Dingxin Pan et al.
BLOOD (2015)
Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double-blind, placebo-controlled, cross-over study
F. Lussana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459
R. Pettipher et al.
ALLERGY (2014)
Dual PDE3/4 and PDE4 Inhibitors: Novel Treatments For COPD and Other Inflammatory Airway Diseases
Katharine H. Abbott-Banner et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Platelets and allergic inflammation
C. Page et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Inhaled Drug Delivery in the Hands of the Patient
Federico Lavorini
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2014)
Cysteinyl Leukotriene Receptor-1 Antagonists as Modulators of Innate Immune Cell Function
A. J. Theron et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Inhaled Drug Delivery in the Hands of the Patient
Sandra D. Anderson
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2014)
Long-acting bronchodilators in COPD: where are we now and where are we going?
Mario Cazzola et al.
BREATHE (2014)
Theophylline
Peter J. Barnes
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
HEPARIN PROTECTS BALB/c MICE FROM MITE-INDUCED AIRWAY ALLERGIC INFLAMMATION
L. S. Fu et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2013)
Prostaglandin D2 pathway upregulation: Relation to asthma severity, control, and TH2 inflammation
Merritt L. Fajt et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Michel Laviolette et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease
Peter J. Barnes
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
cAMP regulation of airway smooth muscle function
Charlotte K. Billington et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2013)
Correction: The Cellular and Molecular Basis of Bitter Tastant-Induced Bronchodilation
Cheng-Hai Zhang et al.
PLOS BIOLOGY (2013)
Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials
Lui G. Franciosi et al.
LANCET RESPIRATORY MEDICINE (2013)
A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma
N. Barnes et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma
Yasmine S. Wasfi et al.
RESPIRATORY MEDICINE (2012)
Pharmacologic Profile of OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist That Inhibits Mast Cell-Dependent Activation of T Helper 2 Lymphocytes and Eosinophils
Roy Pettipher et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Effects of Interleukin-13 Blockade on Allergen-induced Airway Responses in Mild Atopic Asthma
Gail M. Gauvreau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma
Jonathan Corren et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Mechanisms of Corticosteroid Resistance in Severe Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Ian M. Adcock et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Locally available heparin modulates inflammatory cell recruitment in a manner independent of anticoagulant activity
Rebecca Lever et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension
Hiroshi Fujita et al.
HEART AND VESSELS (2010)
Phosphodiesterase 4B is essential for TH2-cell function and development of airway hyperresponsiveness in allergic asthma
S. -L. Catherine Jin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Thymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-dependent pathway
Abdelhabib Semlali et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
IgE, mast cells, basophils, and eosinophils
Kelly D. Stone et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Call for withdrawal of LABA single-therapy inhaler in asthma
Richard Beasley et al.
LANCET (2010)
Bronchodilatory Effect of the PPAR-γ Agonist Rosiglitazone in Smokers With Asthma
M. Spears et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor
Sailaja Paruchuri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
TSLP Conditions the Lung Immune Environment for the Generation of Pathogenic Innate and Antigen-Specific Adaptive Immune Responses
Mark B. Headley et al.
JOURNAL OF IMMUNOLOGY (2009)
IgE in allergy and asthma today
Hannah J. Gould et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Effect of an interieukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies
Sally Wenzel et al.
LANCET (2007)
Relaxin plays an important role in the regulation of airway structure and function
Chrishan S. Samuel et al.
ENDOCRINOLOGY (2007)
Affinity and kinetics of different heparins binding to P- and L-selectin
Dirk Simonis et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Interference of methysergide, a specific 5-hydroxytryptamine receptor antagonist, with airway chronic allergic inflammation and remodelling in a murine model of asthma
C. Lima et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2007)
The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one]
Victoria Boswell-Smith et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Platelet activation in allergic asthma patients during allergen challenge with Dermatophagoides pteronyssinus
K Kowal et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2006)
Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma
Paul M. O'Byrne et al.
CHEST (2006)
Antiinflammatory action of glucocorticoids - New mechanisms for old drugs
T Rhen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses
K Terawaki et al.
JOURNAL OF IMMUNOLOGY (2005)
Differences in airway remodeling between subjects with severe and moderate asthma
C Pepe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
A Rho kinase inhibitor, Y-27632 inhibits pulmonary eosinophilia. bronchoconstriction and airways hyperresponsiveness in allercric mice.
PJ Henry et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2005)
Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease
BJ Lipworth
LANCET (2005)
Involvement of RhoA-mediated Ca2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice -: art. no. 4
Y Chiba et al.
RESPIRATORY RESEARCH (2005)
Relaxin's physiological roles and other diverse actions
OD Sherwood
ENDOCRINE REVIEWS (2004)
Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma
ST Holgate et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma
R Djukanovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7:: In vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes
SJ Smith et al.
MOLECULAR PHARMACOLOGY (2004)
Blockade of cell adhesion by a small molecule selectin antagonist attenuates myocardial ischemia/reperfusion injury
Y Onai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Platelets are essential for leukocyte recruitment in allergic inflammation
SC Pitchford et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor
K Hashimoto et al.
THORAX (2002)
Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism
L Fregonese et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP
FG Gervais et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis
C Vancheri et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Regulation of peroxisome proliferator-activated receptor γ expression in human asthmatic airways -: Relationship with proliferation, apoptosis, and airway remodeling
L Benayoun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
M Solèr et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation
A Eckly et al.
THROMBOSIS AND HAEMOSTASIS (2001)
Eosinophils in asthma and other allergic diseases
AJ Wardlaw et al.
BRITISH MEDICAL BULLETIN (2000)
Share Paper
